PRX Announces FDA Approval For Leflunomide Tablets
Tweet Send to a Friend
Par Pharmaceutical Companies (NYSE: PRX) announced that its wholly-owned subsidiary, Kali ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


